Kaur Gagandeep, Batra Sanjay
Environmental Toxicology PhD program, 207 Health Research Center, Southern University and A&M College, Baton Rouge, LA, USA.
Immunol Cell Biol. 2016 Oct;94(9):812-820. doi: 10.1038/icb.2016.50. Epub 2016 Jun 14.
The immunoproteasome is a proteasome variant that is found only in jawed vertebrates. It is responsible for degrading intracellular proteins to generate a major source of peptides with substantial major histocompatibility complex I binding affinity. The immunoproteasome also has roles in T-cell survival, differentiation and proliferation in various pathological conditions. In humans, any alteration in the expression, assembly or function of the immunoproteasome can lead to cancer, autoimmune disorders or inflammatory diseases. Although the roles of the immunoproteasome in cancer and neurodegenerative disorders have been extensively studied, its significance in other disease conditions has only recently become known. Therefore, there is renewed interest in the development of drugs, vaccines and biomarkers that target the immunoproteasome. The current review highlights the involvement of this complex in disease pathology in addition to the advances made in immunoproteasome research.
免疫蛋白酶体是一种仅在有颌脊椎动物中发现的蛋白酶体变体。它负责降解细胞内蛋白质,以产生具有大量主要组织相容性复合体I结合亲和力的肽的主要来源。免疫蛋白酶体在各种病理条件下的T细胞存活、分化和增殖中也发挥作用。在人类中,免疫蛋白酶体的表达、组装或功能的任何改变都可能导致癌症、自身免疫性疾病或炎症性疾病。尽管免疫蛋白酶体在癌症和神经退行性疾病中的作用已得到广泛研究,但其在其他疾病条件下的意义直到最近才为人所知。因此,针对免疫蛋白酶体的药物、疫苗和生物标志物的开发重新引起了人们的兴趣。本综述除了强调免疫蛋白酶体研究取得的进展外,还突出了该复合体在疾病病理学中的作用。